The neuropeptide galanin, which is widely expressed in brain and peripheral tissues, exerts a broad range of physiological effects. Pharmacological studies using peptide analogues have led to speculation about multiple galanin receptor subtypes. Since 1994, a total of three G-protein-coupled receptor (GPCR) subtypes for galanin have been cloned (GAL1, gal2 and gal3). Potent, selective antagonists are yet to be found for any of the cloned receptors. Major challenges in this field include linking the receptor clones with each of the known physiological actions of galanin and evaluating the evidence for additional galanin receptor subtypes.
机构:
Stockholm Univ, Dept Neurochem & Neurotoxicol, Arrheniuslabs, S-10691 Stockholm, SwedenStockholm Univ, Dept Neurochem & Neurotoxicol, Arrheniuslabs, S-10691 Stockholm, Sweden
Florén, A
Land, T
论文数: 0引用数: 0
h-index: 0
机构:
Stockholm Univ, Dept Neurochem & Neurotoxicol, Arrheniuslabs, S-10691 Stockholm, SwedenStockholm Univ, Dept Neurochem & Neurotoxicol, Arrheniuslabs, S-10691 Stockholm, Sweden
Land, T
Langel, Ü
论文数: 0引用数: 0
h-index: 0
机构:
Stockholm Univ, Dept Neurochem & Neurotoxicol, Arrheniuslabs, S-10691 Stockholm, SwedenStockholm Univ, Dept Neurochem & Neurotoxicol, Arrheniuslabs, S-10691 Stockholm, Sweden